Julie Bauman, MD

George Washington University Cancer Center
Washington, DC

Disclosures:

• Employment: George Washington University:Cancer Center Director, Associate Dean of Cancer, Professor of Medicine:Employee
• Compensation: BlueDot Bio: Consultant, Compensation Payment-End Date: to present ;CUE: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present
• Ownership: none
• Leadership: none

Presentation(s):

• 328 - Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)

  Tuesday, October 1, 2024
  5:15 PM – 5:25 PM ET

• 3609 - FIERCE-HN: A Multicenter, Randomized, Placebo-Controlled, Phase 3 Study of Ficlatuzumab + Cetuximab in Pts W/ Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

  Wednesday, October 2, 2024
  10:30 AM – 11:45 AM ET